eXoZymes

eXoZymes

Biotechnology
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.

$36.2M

Market Cap • 11/13/2026

2019

(7 years)

Founded

2024

(2 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

16,5

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,2

EPS

—

Market Cap

Market Cap

36,2M

EV

33,9M

EV/Revenue

0

EV/EBITDA

-3,1

EV/EBIT

-3,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-28,6M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

142,9%

Capex/OCF

-6%

SBC/OCF

—

% PPE

31,6%

% Goodwill

0%

ROE

—

ROIC

—

Leverage

N.D./EBITDA

0,2

Debt/Equity

0%

Current Ratio

2,3

Quick Ratio

2,1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium